• Fields of application

  • Focus on

  • Content type

  • Showcase

  • Regional News

Belgium leads the way in advancing ATMPs

ATMPs (advanced therapy medicinal products) are expected to reach a global value of 80 billion euro in 2032. While it can be tempting to try to go it alone, the fastest and most intelligent way to advance is by advancing together. The event, Advanced Therapies in Belgium, presents such an occasion, offering a space for innovative ideas and featuring speakers from the forefront of the Belgian and international ATMP innovation.
At the heart of Europe, Benelux is like a drop of ink spreading its influence internationally; an in-depth study conducted by KBC Securities placed Belgium as Europe’s leading country for biotech in 2024. This year's edition of Knowledge for Growth, hosted by the life sciences cluster flanders.bio celebrating their 20th anniversary, highlighted the vibrant Flemish life sciences ecosystem. The event took place in Antwerp, Belgium on May 15th and 16th, where industry professionals, scientists, investors, policymakers, and more gathered to share their knowledge and insights and answer why the region of Flanders, and the Benelux overall, are doing so well in this vibrant landscape.
The Observational Medical Outcomes Partnership (OMOP) Common Data Model (CDM) is a standardized framework designed by the Observational Health Data Sciences and Informatics (OHDSI) community. This open-science community aims to improve the quality of healthcare by providing guidelines for a more harmonized approach to data science.
In a world where our health is paramount, fatty liver disease, known as metabolic dysfunction-associated steatotic liver disease (MASLD), is climbing the ranks of health concerns we can't afford to ignore. Imagine your liver, which controls over 500 vital functions, including the body's detox powerhouse, getting clogged with fat. Alarmingly, about 30% of people globally are wrestling against this silent epidemic. It's a complex disease with various risk factors, especially related to gender and sex hormonal differences, making a one-size-fits-all treatment difficult.
The number of offshore wind farms in the North Sea is exponentially increasing. Their construction responds to the urgent need to transition to green energy production and carbon neutrality. The installation of these man-made structures has a notable impact on the marine ecosystem. Some positive impacts include providing a new home for various animals, and offering shelter, food, and breeding grounds. However, there have been observations of black sediment patches in the sampled sediments near the turbine foundations, suggesting a high input of organic matter into the sediment, altering natural biogeochemical processes.
After several years of dismal market activity, 2024 is already looking up for deals in the pharmaceutical industry, with a recent flurry of billion-dollar mergers and acquisitions. Is this trend being driven by the impending loss of revenue caused by soon-to-expire blockbuster drug patents? And what does it mean for earlier-stage biotech startups?
Personalized healthcare is characterized by tailoring treatments to each individual patient’s needs. Despite evident benefits, implementing such a system is not straightforward. The ATHENA project consortium has successfully devised a set of building blocks to address the challenges associated. Both technological and governance tools were developed that can now be used on a larger scale to catalyze the transition towards personalized medicine and care.
The emergence of artificial intelligence and machine learning accelerates research and innovation across various sectors, particularly in healthcare. The potential for the development of innovative diagnostic tools and therapies based on insights from health data is limitless. However, progress should never compromise the privacy of patients. It’s a delicate balance that is essential to maintain.
Belgium is one of the top countries in the world for in vitro fertilization (IVF). Despite the high cumulative success rates of these interventions, disproportionally little attention has been given to the health of both mother and child during and after pregnancy. With the HEART (High risk for pre-Eclampsia after Assisted Reproductive Technology) project, Belgian researchers strive to understand why some women have an increased risk for pre-eclampsia after IVF and whether biomarkers can be identified to estimate these risks early in pregnancy or even before conception. They aim to raise the standard from successful conception to improved child and maternal health.
  • Fields of application

  • Focus on

  • Content type

  • Showcase

  • Regional News

ATMPs (advanced therapy medicinal products) are expected to reach a global value of 80 billion euro in 2032. While it can be tempting to try to go it alone, the fastest and most intelligent way to advance is by advancing together. The event, Advanced Therapies in Belgium, presents such an occasion, offering a space for innovative ideas and featuring speakers from the forefront of the Belgian and international ATMP innovation.
At the heart of Europe, Benelux is like a drop of ink spreading its influence internationally; an in-depth study conducted by KBC Securities placed Belgium as Europe’s leading country for biotech in 2024. This year's edition of Knowledge for Growth, hosted by the life sciences cluster flanders.bio celebrating their 20th anniversary, highlighted the vibrant Flemish life sciences ecosystem. The event took place in Antwerp, Belgium on May 15th and 16th, where industry professionals, scientists, investors, policymakers, and more gathered to share their knowledge and insights and answer why the region of Flanders, and the Benelux overall, are doing so well in this vibrant landscape.
The Observational Medical Outcomes Partnership (OMOP) Common Data Model (CDM) is a standardized framework designed by the Observational Health Data Sciences and Informatics (OHDSI) community. This open-science community aims to improve the quality of healthcare by providing guidelines for a more harmonized approach to data science.
In a world where our health is paramount, fatty liver disease, known as metabolic dysfunction-associated steatotic liver disease (MASLD), is climbing the ranks of health concerns we can't afford to ignore. Imagine your liver, which controls over 500 vital functions, including the body's detox powerhouse, getting clogged with fat. Alarmingly, about 30% of people globally are wrestling against this silent epidemic. It's a complex disease with various risk factors, especially related to gender and sex hormonal differences, making a one-size-fits-all treatment difficult.
The number of offshore wind farms in the North Sea is exponentially increasing. Their construction responds to the urgent need to transition to green energy production and carbon neutrality. The installation of these man-made structures has a notable impact on the marine ecosystem. Some positive impacts include providing a new home for various animals, and offering shelter, food, and breeding grounds. However, there have been observations of black sediment patches in the sampled sediments near the turbine foundations, suggesting a high input of organic matter into the sediment, altering natural biogeochemical processes.
After several years of dismal market activity, 2024 is already looking up for deals in the pharmaceutical industry, with a recent flurry of billion-dollar mergers and acquisitions. Is this trend being driven by the impending loss of revenue caused by soon-to-expire blockbuster drug patents? And what does it mean for earlier-stage biotech startups?
Personalized healthcare is characterized by tailoring treatments to each individual patient’s needs. Despite evident benefits, implementing such a system is not straightforward. The ATHENA project consortium has successfully devised a set of building blocks to address the challenges associated. Both technological and governance tools were developed that can now be used on a larger scale to catalyze the transition towards personalized medicine and care.
The emergence of artificial intelligence and machine learning accelerates research and innovation across various sectors, particularly in healthcare. The potential for the development of innovative diagnostic tools and therapies based on insights from health data is limitless. However, progress should never compromise the privacy of patients. It’s a delicate balance that is essential to maintain.
Belgium is one of the top countries in the world for in vitro fertilization (IVF). Despite the high cumulative success rates of these interventions, disproportionally little attention has been given to the health of both mother and child during and after pregnancy. With the HEART (High risk for pre-Eclampsia after Assisted Reproductive Technology) project, Belgian researchers strive to understand why some women have an increased risk for pre-eclampsia after IVF and whether biomarkers can be identified to estimate these risks early in pregnancy or even before conception. They aim to raise the standard from successful conception to improved child and maternal health.